Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $345.97 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $139.40 | 9 | $0 (2023) |
| Organogenesis Inc. | $121.34 | 1 | $0 (2024) |
| Medtronic, Inc. | $48.89 | 3 | $0 (2023) |
| SPR Therapeutics, Inc | $18.59 | 1 | $0 (2023) |
| FORTE BIO-PHARMA LLC | $17.75 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.34 | 1 | Organogenesis Inc. ($121.34) |
| 2023 | $149.71 | 9 | Merck Sharp & Dohme LLC ($101.45) |
| 2022 | $74.92 | 5 | Merck Sharp & Dohme LLC ($37.95) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Organogenesis Inc. | APLIGRAF (Device), PURAPLY WOUND MATRIX, AFFINITY | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: WOUND CARE | ||||||
| 10/09/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 01/30/2023 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: Pain management | ||||||
| 01/18/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/19/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | FORTE BIO-PHARMA LLC | PROLATE (Drug), PROLATE, NALOCET | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Pain | ||||||
| 09/21/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,492 | 3,511 | $843,276 | $195,496 |
| 2022 | 9 | 1,554 | 2,885 | $536,818 | $168,307 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 439 | 1,423 | $420,621 | $103,029 | 24.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 404 | 1,226 | $334,660 | $74,603 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $27,041 | $5,391 | 19.9% |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | Office | 2023 | 312 | 446 | $22,300 | $4,452 | 20.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 64 | 64 | $12,736 | $3,372 | 26.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 127 | 127 | $5,461 | $1,817 | 33.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 74 | 151 | $16,148 | $1,697 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $4,310 | $1,135 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 442 | 1,108 | $283,648 | $89,257 | 31.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 418 | 952 | $171,360 | $57,864 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $32,226 | $8,399 | 26.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 103 | 103 | $20,497 | $5,364 | 26.2% |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | Office | 2022 | 293 | 369 | $18,450 | $3,928 | 21.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 114 | 114 | $4,902 | $1,628 | 33.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 55 | 108 | $3,672 | $1,307 | 35.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 36 | 36 | $1,296 | $443.11 | 34.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 13 | $767.00 | $117.46 | 15.3% |
About Mariah Harmon, APRN
Mariah Harmon, APRN is a Nurse Practitioner healthcare provider based in Woodward, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/17/2021. The National Provider Identifier (NPI) number assigned to this provider is 1992464978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mariah Harmon, APRN has received a total of $345.97 in payments from pharmaceutical and medical device companies, with $121.34 received in 2024. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($345.97).
As a Medicare-enrolled provider, Harmon has provided services to 3,046 Medicare beneficiaries, totaling 6,396 services with total Medicare billing of $363,803. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Woodward, OK
- Active Since 12/17/2021
- Last Updated 01/14/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1992464978
Products in Payments
- BELSOMRA (Drug) $139.40
- APLIGRAF (Device) $121.34
- INTELLIS ADAPTIVESTIM (Device) $48.89
- SPRINT PNS System (Device) $18.59
- PROLATE (Drug) $17.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.